Retatrutide | China | Manufacturer
US$ 26.89
health benefits of glp-1 agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies The Benefits of GLP-1 Therapy:
Description
In the ELIXA trial, Pfeffer et al 27 evaluated the effect of lixisenatide in patients with type 2 diabetes with myocardial infarction or unstable angina admission in the previous 180 days
Lifestyle and supplement approaches Medication is not the only path
International Federation of Obstetrics and Gynaecology (FIGO)
Various studies have found that, among patients with type 2 diabetes, a history of myocardial infarction or stroke, or arteriosclerotic cardiovascular disease, liraglutide use was associated with a lower incidence of cardiovascular disease than in the control group [16]
A study published in Frontiers in Endocrinology reported that these medications may increase the risk of pregnancy complications and birth defects
Alkas J, Bosi A, Sjolander A, Barany P, Elinder CG, Fu EL
